Nomura Inc.
NMR | NYSE
$9.38
-$0.09 (-0.95%)
At close: Oct 30, 2026, 4:00 PM ET
$9.43
+$0.05 (+0.53%)
Pre-market:
Nov 2, 2026, 8:28 AM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | 4.76T | 4.51T | 3.97T | 2.3T | 1.37T | 1.41T |
Cost of Revenue | 2.59T | 2.84T | 2.6T | 1.15T | 230.11B | 215.36B |
Gross Profit | 2.17T | 1.66T | 1.38T | 1.14T | 1.14T | 1.2T |
Operating Income | 539.82B | 471.96B | 273.85B | 149.47B | 226.62B | 230.67B |
Interest Income | 2.67T | 2.93T | 2.62T | 1.11T | 284.22B | 356.47B |
Pretax Income | 539.82B | 471.96B | 273.85B | 149.47B | 226.62B | 230.67B |
Net Income | 362.13B | 340.74B | 165.86B | 92.79B | 143B | 153.12B |
Selling & General & Admin | 1.37T | 732.39B | 673.52B | 605.79B | 529.51B | 507.91B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 256.57B | 458.02B | 430.64B | 389.71B | 387.59B | 460.2B |
Operating Expenses | 1.63T | 1.19T | 1.1T | 995.5B | 917.09B | 968.11B |
Interest Expense | 2.59T | 2.84T | 2.6T | 1.15T | 230.11B | 215.36B |
Selling & Marketing Expenses | 221.86B | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.22T | 4.03T | 3.7T | 2.15T | 1.15T | 1.18T |
Income Tax Expense | 165.44B | 124.71B | 96.63B | 57.8B | 80.09B | 70.27B |
Shares Outstanding (Basic) | 2.94B | 2.96B | 3.02B | 3.01B | 3.06B | 3.06B |
Shares Outstanding (Diluted) | 3.04B | 3.07B | 3.14B | 3.11B | 3.16B | 3.15B |
EPS (Basic) | 123.08 | 115.30 | 54.97 | 30.86 | 46.68 | 50.11 |
EPS (Diluted) | 118.99 | 111.03 | 52.75 | 29.74 | 45.23 | 48.63 |
EBITDA | 608.09B | 533.62B | 335.19B | 210.9B | 286.15B | 294.52B |
EBIT | 539.82B | 471.96B | 273.85B | 149.47B | 226.62B | 230.67B |
Depreciation & Amortization | 68.27B | 61.65B | 61.34B | 61.42B | 59.52B | 63.85B |
Add to Watchlist
Select watchlists to add or remove NMR